Medstar Health Research Institute /ID# 128683

Washington D.C., District of Columbia 20010

0 studies enrolling now · 1 studies all time

What they study most

Chronic Hepatitis C Virus (HCV) Infection Genotype 1

Studies at this site

• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection — Completed